GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP)

Market Open
12 Jun, 16:17
NASDAQ (CM) NASDAQ (CM)
$
0. 44
+0
+0.5747%
$
5.07M Market Cap
- P/E Ratio
- Div Yield
694,205 Volume
-10.8 Eps
$ 0.43
Previous Close
Investors:
Add Transaction
Day Range
0.43 0.45
Year Range
0.26 3.85
Want to track GTBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

GT Biopharma, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
CGL
Chester Gary Lloyd Coston, McIsaac & Partners
17,092 $13,417.22 $7,520.48 -$5,896.74 -43.95%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
3,000 $2,356 $1,320 -$1,036 -43.97%